Background: Increased incidence of small differentiated thyroid cancer (DTC) has
emphasized the need for risk stratification and individualized disease management for these …

Background: This study was conducted to compare the staging systems for the prediction of
long-term disease status in patients with well-differentiated thyroid carcinoma (WDTC), and …

Aim The aim of this study was to validate the effectiveness of delayed risk stratification (DRS)
in predicting structural progression and compare the predictive value of American Thyroid …

Background: A risk-adapted approach to management of thyroid cancer requires risk
estimates that change over time based on response to therapy and the course of the …

Background: The risk of recurrence in patients with differentiated thyroid cancer (DTC) can
be estimated based on their response to initial therapy. The aim of this study was to evaluate …

Context: Although response to therapy assessment is a validated tool for dynamic risk
stratification in patients with differentiated thyroid cancer (DTC) treated with total …

Objective To describe the risk of structural disease recurrence in a cohort of patients with
differentiated thyroid cancer selected for treatment with either thyroid lobectomy or total …

Background In differentiated thyroid cancer (DTC) patients at intermediate risk of
recurrences, no evidences are provided regarding the optimal radioactive iodine (RAI) …

The stratification of patients with differentiated thyroid cancer based on their initial risk of
recurrence, according to specific clinical, histopathological and perioperative data, is an …

Introduction After initial treatment, differentiated thyroid cancer (DTC) patients are stratified
as low and high risk based on clinical/pathological features. Recently, a risk stratification …